CFDE Data Portal | Search FURIN

	Label	Description
	FURIN Gene (Entity type)	ENSG00000140564 - furin, paired basic amino acid cleaving enzyme
	GSE186810,GSE186813 3 V 5 FURIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE158456 1 V 3 FURIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE186810,GSE186813 7 V 5 FURIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE158456 2 V 3 FURIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	PTPN12 Gene (Entity type)	ENSG00000127947 - protein tyrosine phosphatase non-receptor type 12
	GSE186810,GSE186813 7 V 0 FURIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE186810,GSE186813 7 V 5 FURIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE186810,GSE186813 2 V 0 FURIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	PLOD3 Gene (Entity type)	ENSG00000106397 - procollagen-lysine,2-oxoglutarate 5-dioxygenase 3

FURIN

ENSG00000140564 - furin, paired basic amino acid cleaving enzyme

GSE186810,GSE186813 3 V 5 FURIN MOUSE UP

A Gene Set from LINCS

GSE158456 1 V 3 FURIN MOUSE DN

A Gene Set from LINCS

GSE186810,GSE186813 7 V 5 FURIN MOUSE UP

A Gene Set from LINCS

GSE158456 2 V 3 FURIN MOUSE DN

A Gene Set from LINCS

PTPN12

ENSG00000127947 - protein tyrosine phosphatase non-receptor type 12

GSE186810,GSE186813 7 V 0 FURIN MOUSE UP

A Gene Set from LINCS

GSE186810,GSE186813 7 V 5 FURIN MOUSE DN

A Gene Set from LINCS

GSE186810,GSE186813 2 V 0 FURIN MOUSE DN

A Gene Set from LINCS

PLOD3

ENSG00000106397 - procollagen-lysine,2-oxoglutarate 5-dioxygenase 3

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.